State of Wyoming’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$236K Sell
16,167
-11,249
-41% -$149K 0.02% 871
2026
Q1
$378K Buy
+27,416
New +$413K 0.04% 526
2025
Q4
Sell
-1,375
Closed -$25.5K 1851
2025
Q3
$25.5K Sell
1,375
-15,152
-92% -$238K ﹤0.01% 1686
2025
Q2
$264K Sell
16,527
-6,599
-29% -$118K 0.03% 719
2025
Q1
$449K Sell
23,126
-7,785
-25% -$164K 0.06% 282
2024
Q4
$681K Buy
30,911
+9,530
+45% +$183K 0.09% 142
2024
Q3
$360K Sell
21,381
-19,308
-47% -$287K 0.05% 332
2024
Q2
$486K Buy
40,689
+10,874
+36% +$121K 0.08% 132
2024
Q1
$330K Buy
29,815
+14,203
+91% +$145K 0.06% 313
2023
Q4
$135K Buy
15,612
+2,275
+17% +$17.7K 0.03% 794
2023
Q3
$102K Buy
+13,337
New +$100K 0.02% 842

Other funds holding CLBT

State of Wyoming's CLBT Position: Q2 2026 in Review

State of Wyoming reduced its Cellebrite (CLBT) stake by 41% in Q2 2026, selling an estimated $149K and leaving 16,167 shares worth $236K. The position accounts for 0.02% of the portfolio, ranked #871.

State of Wyoming first reported a position in CLBT in Q3 2023 and has held it in 11 quarters since. The position peaked at $681K in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • State of Wyoming held 16,167 shares of Cellebrite worth $236K as of Q2 2026.
  • State of Wyoming sold 11,249 Cellebrite shares in Q2 2026, an estimated $149K.
  • Cellebrite made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #871 holding.
  • State of Wyoming first reported a position in Cellebrite in Q3 2023 and has held it in 11 quarters since.
  • State of Wyoming's Cellebrite position peaked at $681K in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.